NLM Logo

Pyridoxine-dependent epilepsy MeSH Supplementary Concept Data 2024


MeSH Supplementary
Pyridoxine-dependent epilepsy
Unique ID
C536254
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C536254
Entry Term(s)
Aasa Dehydrogenase Deficiency
Epilepsy, Pyridoxine-Dependent
Pyridoxine dependency
Pyridoxine dependency with seizures
Pyridoxine-Dependent Seizures
Vitamin B6-Dependent Seizures
Heading Mapped to
*Epilepsy
Frequency
122
Note
A hereditary combination of various seizure types that occur in neonates and are unresponsive to standard ANTICONVULSANT AGENTS. They can be treated only by the immediate administration of PYRIDOXINE HYDROCHLORIDE. This treatment must continue or the seizures will re-appear. Some patients show developmental delay. Prevalence is 1 in 400,000 to 700,000 births. Germline mutations in the ALDH7A1 gene have been identified. OMIM: 266100
Date of Entry
2010/08/25
Revision Date
2015/08/18
Pyridoxine-dependent epilepsy Preferred
page delivered in 0.005s